OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

9480	Companies
185531	Keywords
117925	Articles
99377	Press releases

Home
Companies
OXURION

BRIEF

published on 07/10/2025 at 17:50, 4 months 26 days ago

Oxurion Clears Regulatory Hurdle in Axiodis Acquisition

Acquisition Regulatory Approval Oxurion Axiodis FDI Procedure
PRESS RELEASE

published on 07/10/2025 at 17:45, 4 months 26 days ago

Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis
Oxurion NV fulfills acquisition condition of Axiodis CRO with approval from French Ministry, finalizes financing for transaction closure within 30 days

Acquisition Financing French Ministry Oxurion NV Axiodis CRO
BRIEF

published on 07/04/2025 at 18:05, 5 months 1 day ago

Oxurion Boosts Voting Rights with Recent Capital Increase

Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/04/2025 at 18:00, 5 months 1 day ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC's 4 convertible bonds conversion led to a EUR 100,000 capital increase for Oxurion, aiding in focusing on vision preservation for elderly. Updated share capital and voting rights revealed

Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/03/2025 at 18:05, 5 months 2 days ago

Oxurion Reports Shareholding Changes by Atlas Special Opportunities

Transparency Shareholding Legislation Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/03/2025 at 18:00, 5 months 2 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications, crossing under thresholds due to selling of voting securities. Company combines therapeutic innovation with clinical research technologies

Clinical Research Oxurion NV Therapeutic Innovation Transparency Notifications Voting Securities
BRIEF

published on 06/30/2025 at 18:05, 5 months 5 days ago

Oxurion Reports Transparency Notification from Atlas Special Opportunities

Transparency Notification Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/30/2025 at 18:00, 5 months 5 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC as it crosses under 10% shareholding threshold by selling voting securities. Company focused on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
BRIEF

published on 06/25/2025 at 18:05, 5 months 10 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/25/2025 at 18:00, 5 months 10 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding below the threshold. The biopharmaceutical company is focused on therapeutic innovation and clinical research technologies

Technology Clinical Research Transparency Notification Biopharmaceutical Oxurion NV

Accesswire

Published on 12/05/2025 at 19:20, 14 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 49 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 14 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 34 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 19 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 35 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 7 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 18 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 42 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 47 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 16 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 23 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 10 hours 49 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day 1 hour ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day 1 hour ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE